Clinical trial
Protocollo Sulla Valutazione Del RischiO cardioVAscolare Nel Crohn e ColIte Ulcerosa (PROVACI). Estimation of Cardiovascular Risk in Crohn's Disease and Ulcerative Colitis
NCT07095634 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protocollo Sulla Valutazione Del RischiO cardioVAscolare Nel Crohn e ColIte Ulcerosa (PROVACI). Estimation of Cardiovascular Risk in Crohn's Disease and Ulcerative Colitis
- Lead sponsor
- IRCCS Policlinico S. Donato
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- February 7, 2025
- Completion date
- June 30, 2027
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af), crohn disease, heart failure, ischemic heart disease, myocardial infarction, stroke, thromboembolism, transient ischemic attack (tia), ulcerative colitis